These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 36738184)

  • 1. Clinical Outcomes of COVID‑19 Patients with Rheumatic and Musculoskeletal Diseases: A Single Centre Cohort Study.
    Mazeda C; Barcelos A
    Acta Med Port; 2023 Feb; 36(2):140-141. PubMed ID: 36738184
    [No Abstract]   [Full Text] [Related]  

  • 2. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months.
    Karaarslan F; Güneri FD; Kardeş S
    Clin Rheumatol; 2022 Jan; 41(1):289-296. PubMed ID: 34713356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Hyrich KL; Gianfrancesco M; Machado PM; Yazdany J; Robinson PC
    Ann Rheum Dis; 2022 Nov; 81(11):e223. PubMed ID: 32895239
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Correa-Fernández J; Sanz-Gómez S; Navarro-Compán V;
    Clin Exp Rheumatol; 2022 May; 40(5):1062-1063. PubMed ID: 35084328
    [No Abstract]   [Full Text] [Related]  

  • 5. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
    Al Nokhatha S; MacEoin N; Conway R
    Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
    [No Abstract]   [Full Text] [Related]  

  • 6. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
    Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
    Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
    Kearsley-Fleet L; Chang ML; Lawson-Tovey S; Costello R; Fingerhutová Š; Švestková N; Belot A; Aeschlimann FA; Melki I; Koné-Paut I; Eulert S; Kallinich T; Berkun Y; Uziel Y; Raffeiner B; Oliveira Ramos F; Clemente D; Dackhammar C; Wulffraat NM; Waite H; Strangfeld A; Mateus EF; Machado PM; ; ; Natter M; Hyrich KL
    Ann Rheum Dis; 2022 Jul; 81(7):998-1005. PubMed ID: 35338032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
    Nikiphorou E; Alpizar-Rodriguez D; Gastelum-Strozzi A; Buch M; Peláez-Ballestas I
    Rheumatology (Oxford); 2021 May; 60(5):2040-2045. PubMed ID: 33496334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
    Dejaco C; Bijlsma JW; Buttgereit F
    Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
    [No Abstract]   [Full Text] [Related]  

  • 10. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fears and hopes of patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic across Europe. Results from the REUMAVID study (phase 1 and phase 2).
    Garrido-Cumbrera M; Christen L; Marzo-Ortega H; Correa-Fernández J; Sanz-Gomez S; Navarro-Compán V
    Musculoskeletal Care; 2023 Sep; 21(3):932-935. PubMed ID: 36883603
    [No Abstract]   [Full Text] [Related]  

  • 12. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
    Karaarslan F; Demircioğlu Güneri F; Kardeş S
    Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'.
    Smerilli G; Cipolletta E; Moscioni E; Francioso F; Risa AM; Maccarrone V; Zompa D; Di Matteo A; Di Carlo M; De Angelis R; Salaffi F; Filippucci E; Grassi W
    Ann Rheum Dis; 2021 Oct; 80(10):e168. PubMed ID: 33962960
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.
    Boyarsky BJ; Ruddy JA; Connolly CM; Ou MT; Werbel WA; Garonzik-Wang JM; Segev DL; Paik JJ
    Ann Rheum Dis; 2021 Aug; 80(8):1098-1099. PubMed ID: 33757968
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe COVID-19 and outcomes in patients with rheumatic disease].
    Galicia-Lucas UJ; Ramírez-Pérez AA
    Rev Med Inst Mex Seguro Soc; 2021 Jun; 59(2):127-132. PubMed ID: 34231984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli
    Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F
    Ann Rheum Dis; 2021 Oct; 80(10):e169. PubMed ID: 33962963
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases.
    Boyadzhieva VV; Stoilov NR; Stoilov RM
    Rheumatol Int; 2020 Nov; 40(11):1753-1762. PubMed ID: 32930863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.
    Gamboa-Cárdenas RV; Barzola-Cerrón S; Toledo-Neira D; Reátegui-Sokolova C; Pimentel-Quiroz V; Zevallos-Miranda F; Alarcón GS; Ugarte-Gil M
    Clin Rheumatol; 2021 Nov; 40(11):4725-4734. PubMed ID: 34189675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.
    Kroon FPB; Najm A; Alunno A; Schoones JW; Landewé RBM; Machado PM; Navarro-Compán V
    Ann Rheum Dis; 2022 Mar; 81(3):422-432. PubMed ID: 34876462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.